Healthcare >> CEO Interviews >> January 22, 2001
MICHAEL T. HEFFERNAN R.Ph has been the President of Innovative Clinical
Solutions, Ltd. (formerly PhyMatrix) since December 1998, and became the
CEO and Chairman in July 1999. Mr. Heffernan has served as a company
director with Innovative Clinical Solutions, Ltd. (ICSL) since January
1998, following the acquisition of Clinical Studies, Ltd in October
1997. He has held the position of CEO at Clinical Studies since January
1995. Prior to joining Clinical Studies, Mr. Heffernan held various
sales, marketing and management positions with Eli Lilly & Company. Profile
Solutions?
Mr. Heffernan: Innovative Clinical Solutions, or ICSL, has two main
operating units, pharmaceutical services
